Fort Washington Investment Advisors Inc Bio Techne Corp Transaction History

Fort Washington Investment Advisors Inc

$16.8 Billion
Q2 2025

A detailed history of Fort Washington Investment Advisors Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Fort Washington Investment Advisors Inc holds 439,155 shares of TECH stock, worth $23.4 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

439,155

Previous 333,784 31.57%

Holding current value

$23.4 Million

Previous $19.6 Million 15.46%

% of portfolio

0.13%

Previous 0.12%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 17, 2025	BUY	$46.66 - $58.38 $4.92 Million - $6.15 Million	105,371 Added 31.57%	439,155 $22.6 Million
Q1 2025 Apr 16, 2025	BUY	$58.47 - $78.75 $4.66 Million - $6.28 Million	79,750 Added 31.39%	333,784 $19.6 Million
Q4 2024 Jan 17, 2025	BUY	$66.37 - $78.17 $1.7 Million - $2.01 Million	25,650 Added 11.23%	254,034 $18.3 Million
Q3 2024 Oct 25, 2024	SELL	$70.96 - $82.35 $2.13 Million - $2.47 Million	-29,960 Reduced 11.6%	228,384 $18.3 Million
Q2 2024 Jul 30, 2024	BUY	$62.12 - $84.15 $4.17 Million - $5.65 Million	67,186 Added 35.15%	258,344 $18.5 Million
Q1 2024 May 13, 2024	SELL	$65.98 - $77.09 $3.11 Million - $3.63 Million	-47,150 Reduced 19.79%	191,158 $13.5 Million
Q4 2023 Jan 17, 2024	BUY	$52.83 - $78.22 $1.02 Million - $1.52 Million	19,390 Added 8.86%	238,308 $18.4 Million
Q3 2023 Nov 07, 2023	BUY	$67.52 - $89.42 $2.32 Million - $3.07 Million	34,290 Added 18.57%	218,918 $14.9 Million
Q2 2023 Jul 28, 2023	BUY	$73.76 - $85.98 $1.49 Million - $1.73 Million	20,140 Added 12.24%	184,628 $15.1 Million
Q1 2023 Apr 28, 2023	BUY	$71.62 - $86.62 $2.16 Million - $2.61 Million	30,128 Added 22.42%	164,488 $12.2 Million
Q4 2022 Jan 30, 2023	BUY	$80.67 - $352.29 $8.39 Million - $36.6 Million	104,005 Added 342.63%	134,360 $11.1 Million
Q3 2022 Oct 26, 2022	SELL	$282.54 - $391.85 $485,968 - $673,982	-1,720 Reduced 5.36%	30,355 $8.62 Million
Q2 2022 Aug 05, 2022	BUY	$322.67 - $449.65 $354,937 - $494,615	1,100 Added 3.55%	32,075 $11.1 Million
Q1 2022 May 03, 2022	BUY	$353.85 - $487.79 $2.05 Million - $2.82 Million	5,780 Added 22.94%	30,975 $13.4 Million
Q4 2021 Feb 07, 2022	BUY	$456.15 - $525.06 $1.03 Million - $1.19 Million	2,265 Added 9.88%	25,195 $13 Million
Q3 2021 Nov 09, 2021	SELL	$444.87 - $538.88 $1.23 Million - $1.49 Million	-2,771 Reduced 10.78%	22,930 $11.1 Million
Q2 2021 Aug 09, 2021	SELL	$387.35 - $450.26 $1.06 Million - $1.24 Million	-2,748 Reduced 9.66%	25,701 $11.6 Million
Q1 2021 May 05, 2021	SELL	$314.62 - $411.0 $227,784 - $297,564	-724 Reduced 2.48%	28,449 $10.9 Million
Q4 2020 Feb 03, 2021	SELL	$246.9 - $321.87 $755,760 - $985,244	-3,061 Reduced 9.5%	29,173 $9.26 Million
Q3 2020 Nov 10, 2020	SELL	$232.22 - $282.96 $111,001 - $135,254	-478 Reduced 1.46%	32,234 $7.99 Million
Q2 2020 Jul 31, 2020	SELL	$185.43 - $279.56 $1.71 Million - $2.57 Million	-9,200 Reduced 21.95%	32,712 $8.64 Million
Q1 2020 May 06, 2020	SELL	$161.17 - $221.51 $2.8 Million - $3.85 Million	-17,400 Reduced 29.34%	41,912 $7.95 Million
Q4 2019 Feb 03, 2020	SELL	$189.68 - $222.09 $815,624 - $954,987	-4,300 Reduced 6.76%	59,312 $13 Million
Q3 2019 Nov 08, 2019	SELL	$183.56 - $216.72 $458,900 - $541,800	-2,500 Reduced 3.78%	63,612 $12.4 Million
Q2 2019 Aug 12, 2019	SELL	$188.72 - $215.43 $566,160 - $646,290	-3,000 Reduced 4.34%	66,112 $13.8 Million
Q1 2019 May 10, 2019	SELL	$136.09 - $200.44 $2.89 Million - $4.25 Million	-21,200 Reduced 23.47%	69,112 $13.7 Million
Q3 2018 Nov 07, 2018	SELL	$147.44 - $204.11 $3.87 Million - $5.35 Million	-26,223 Reduced 22.5%	90,312 $18.4 Million
Q4 2017 Feb 12, 2018	BUY	$121.17 - $134.75 $14.1 Million - $15.7 Million	116,535	116,535 $15.1 Million

Others Institutions Holding TECH

# of Institutions

618

Shares Held

160M

Call Options Held

90K

Put Options Held

14.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.09B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Washington Investment Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Fort Washington Investment Advisors Inc with notifications on news.

Account

Fort Washington Investment Advisors Inc Bio Techne Corp Transaction History